Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -8.1% | +4.0% | 2 / 3 | +1.5% | +2.33 pp | -0.56 pp | +4.1% | 0.25 | 9.31 | 192 | +1,5% | 11,0 | −7,5% | 9.31 | 9.74 | −4,4% |
| Pts | 0 | 0 | 8 | 0 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.500 (close price on 2026-10-19)EPS (TTM): 912,9
Financial charts
1.Revenue & growth
VND bn192Q2/26
1.Revenue & growth
VND bn192Q2/26
2.Profit & growth
VND bn10,7Q2/26
3.Profit mix (Penman)
VND bn51,3Q2/26
4.Margins & cost structure
%37.2%Q2/26
5.Returns & cash cycle
% · days3.0%Q2/26
6.Earnings quality & cash
VND bn7,15Q2/26
7.Asset structure
VND bn1.256Q2/26
8.Funding & debt health
VND bn · times1.256Q2/26
9.Revenue backlog
VND bn15,0Q2/26
10.Valuation
times · %9,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %254Q2/26
Adjusted EPS growth, latest quarter
-8.1%
Average adjusted EPS growth, 3 quarters
4.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26